Indus Holdings, Inc. Announces Updated Fourth Quarter Guidance
SALINAS, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) — Indus Holdings, Inc. (“Indus” or the “Company”)…
News
Genmab Announces that Janssen has Submitted a Biologics License Application to U.S. FDA for Amivantamab in Non-small Cell Lung Cancer
Media Release Copenhagen, Denmark, December 3, 2020 Janssen submitted a BLA to U.S. FDA…
OSE Immunotherapeutics and Nantes University Hospital Announce Initiation of a Phase 1/2 Clinical Trial to Evaluate CD28 Antagonist FR104 in Patients Undergoing Renal Transplantation
University Hospital of Nantes will sponsor and conduct the clinical trial OSE Immunotherapeutics will provide…
Issuance of a 4th tranche of €1.5 million of notes convertible into new shares
ISSUANCE OF A 4th TRANCHE OF €1.5 MILLION OF NOTES CONVERTIBLE INTO NEW SHARES…
Intrivo Diagnostics Inks National Distribution Agreements with Concordance Healthcare Solutions and NDC for Access Bio CareStart™ COVID-19 Tests
Major supply chain agreements will ensure broad access to rapid testing solutions for patients and…
Annovis Bio to Present at the New York Academy of Sciences’ Alzheimer’s Disease Therapeutics: Alternatives to Amyloid 2020 Virtual Conference
BERWYN, Pa., Dec. 03, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a…
Akari Therapeutics Announces Publication in American Journal of Pathology Highlighting Potential of Nomacopan in Treatment of Uveitis and Retinal Disease
New data highlight role of leukotriene B4 (LTB4) in the pathophysiology of retinal inflammation and…
Tauriga Sciences, Inc. Introduces its Product Line of CBD Infused Bath Bombs Under the Tauri-Gum Brand
December 3 PR Blood Orange Fragrance Tauri-Gum™ Branded Bath Bomb The Company has Launched its…
Parexel Named Best Contract Research Organization by Scrip
Company recognized for innovative and effective use of real-world data and flexible trial designs BOSTON…
AXIM® Biotechnologies Develops ELISA-Based Neutralizing Antibody Diagnostic Test for COVID-19 and Applies for Patent; Company’s Fourth COVID-19 Test-Focused Patent Application
SAN DIEGO, Dec. 03, 2020 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM”…